Tina A. Khair

Hematology Oncology

195 Stock Street, Suite 304
Hanover, PA 17331

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).

Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 08, 2022

Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.

Randomized study of remote telehealth genetic services versus usual care in oncology practices without genetic counselors.

Journal: Cancer medicine

Published: December 04, 2020

Showing 1-2 of 2

Last Updated: 09/26/2026